Joost van der Mark
Corporate Officer/Principal bij BIOSYENT INC.
Vermogen: 338 263 $ op 31-03-2024
Profiel
Joost van der Mark is the founder of Orphan Canada, Inc. He is currently the Vice President-Corporate Development at BioSyent, Inc. He has previously worked as Vice President-Corporate Development at BioSyent, Inc. from 2015 to 2017 and as Chief Business Officer at Telo Genomics Corp.
from 2017 to 2018.
He also worked as Vice President-Corporate Development at Knight Therapeutics, Inc. Mr. van der Mark holds an MBA from York University and The Schulich School of Business, and a graduate degree from the University of Western Ontario.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BIOSYENT INC.
0.45% | 27-03-2024 | 52 730 ( 0.45% ) | 338 263 $ | 31-03-2024 |
Actieve functies van Joost van der Mark
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOSYENT INC. | Corporate Officer/Principal | 10-09-2018 |
Eerdere bekende functies van Joost van der Mark
| Bedrijven | Functie | Einde |
|---|---|---|
| TELO GENOMICS CORP. | Corporate Officer/Principal | 31-05-2018 |
| BIOSYENT INC. | Corporate Officer/Principal | 01-01-2017 |
| KNIGHT THERAPEUTICS INC. | Corporate Officer/Principal | - |
Orphan Canada, Inc.
 Orphan Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of Knight Therapeutics, Inc., Orphan Canada, Inc. is a Canadian company that manufactures specialty pharmaceuticals. The private company was founded by Jason Flowerday, Joost van der Mark. Orphan Canada was acquired by Knight Therapeutics, Inc. on September 02, 2014. | Founder | - |
Opleiding van Joost van der Mark
| York University | Masters Business Admin |
| University of Western Ontario | Graduate Degree |
| The Schulich School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| BIOSYENT INC. | Health Technology |
| KNIGHT THERAPEUTICS INC. | Health Technology |
| TELO GENOMICS CORP. | Health Services |
| Bedrijven in privébezit | 1 |
|---|---|
Orphan Canada, Inc.
Orphan Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of Knight Therapeutics, Inc., Orphan Canada, Inc. is a Canadian company that manufactures specialty pharmaceuticals. The private company was founded by Jason Flowerday, Joost van der Mark. Orphan Canada was acquired by Knight Therapeutics, Inc. on September 02, 2014. | Health Technology |
